Repurposing Asparaginase Therapy to Target Cisplatin‐Resistant Cancer CellsJ.S. Wang(Sichuan University), Sean G. Rudd(Science for Life Laboratory)Fundamental and Clinical PharmacologyAugust 10, 202510.1111/fcp.70044Cited by 2SaveCiteExport RISWatch citationsRelated PapersA12 The SHP2 Inhibitor RMC-4630 in Patients with KRAS-Mutant Non-Small Cell Lung Cancer: Preliminary Evaluation of a First-in-Man Phase 1 Clinical Trial|Journal of Thoracic Oncology|2020|74